Antonio De Vivo

Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study

Michèle Cavo, Patrizia Tosi, Elena Zamagni et al. · Journal of Clinical Oncology · 2007 · 373 citations · Full text

Medicine, Oncology, Cell Therapy +12

ABL Mutations in Late Chronic Phase Chronic Myeloid Leukemia Patients With Up-Front Cytogenetic Resistance to Imatinib Are Associated With a Greater Likelihood of Progression to Blast Crisis and Shorter Survival: A Study by the GIMEMA Working Party on Chronic Myeloid Leukemia

Simona Soverini, Giovanni Martinelli, Gianantonio Rosti et al. · Journal of Clinical Oncology · 2005 · 372 citations · Full text

Medicine, Hematology, Pharmacology +14

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

Michèle Cavo, Elena Zamagni, Patrizia Tosi et al. · Blood · 2005 · 366 citations

Medicine, Hematology, Oncology +16

Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Pier Luigi Zinzani, Gerardo Musuraca, Monica Tani et al. · Journal of Clinical Oncology · 2007 · 280 citations · Full text

Medicine, Oncology, Pharmacology +17

Endoglin, PlGF and sFlt‐1 as markers for predicting pre‐eclampsia

Antonio De Vivo, G Baviera, Domenico Giordano et al. · Acta Obstetricia Et Gynecologica Scandinavica · 2008 · 211 citations · Full text

Medicine, Maternal Health, Obstetrics +14